Newcastle life sciences spin-out NunaBio seals £810,000 investment
Newcastle University spin-out NunaBio has secured a further £810,000 through regional investment manager Northstar Ventures to expand its work.
NunaBio, which is based at the Newcastle Helix science and business park, was founded in April 2021 to capitalise on technology developed by founders Dr Andrew Pike and Dr Eimer Tuite. The company, later joined by CEO Dr Joe Hedley, has developed novel ways of DNA synthesis which enables it to supply DNA to clients quickly, and at a scale and cost which it says other firms can’t match.
Traditional industry production methods for DNA are not capable of meeting global demand from rapidly expanding markets, including many areas of life sciences, including gene therapy, T cell engineering, diagnostics and targeted biomarker panels. As a result, new processes for the synthesis and rapid scal
